Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site Sort descending
  • Standort
  • Division
  • Business
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Sort descending Standort Division Business Functional Area Erscheinungsdatum
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Der Umsatz Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Der Umsatz Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Der Umsatz Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Der Umsatz Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Der Umsatz Sep 24, 2024
First Line Manager / District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Der Umsatz Okt 09, 2024
县域主任/县域主管 Haerbin (Heilongjiang Province) China International Innovative Medicines Der Umsatz Okt 10, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Der Umsatz Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Der Umsatz Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Der Umsatz Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Der Umsatz Sep 24, 2024
Senior MR Haikou (Hainan Province) China International Innovative Medicines Der Umsatz Sep 05, 2024
(高级)医药代表 /(资深)产品专员 Haikou (Hainan Province) China International Innovative Medicines Der Umsatz Okt 17, 2024
Sr. Manager, ITOT Site Lead Haiyan (Zhejiang Province) China Operations CTS Technology Transformation Sep 03, 2024
Manager, Reg&Dev Policy Japan​ Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 12, 2024
Sr. TA Strategy Lead (Renal Therapy Area) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Aug 07, 2024
P&O Business Partner Development & Biomedical Research Japan Head Office (Japan) (Pharmaceuticals) Japan People & Organization Innovative Medicines Humanressourcen Sep 03, 2024
TA Strategy Lead - Hematology Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Jun 26, 2024
Agile Project Management Lead Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Technology Transformation Jul 01, 2024
Associate Director Pipeline Management Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 10, 2024
Japan Program Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 10, 2024
Manager, TRD Project management Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 16, 2024
Associate Clinical Project Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 18, 2024
SSO Feasibility Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 21, 2024
Associate or Manager, PHAD Japan Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 23, 2024
Senior Lead, TA Medical(General Medicines) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Mai 27, 2024
Associate, Country QA Compliance Head Office (Japan) (Pharmaceuticals) Japan Operations Innovative Medicines Quality Okt 22, 2024
Clinical Biospecimen Senior Scientist Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 03, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit und Finanzen Jun 26, 2024
Lead, Medical Excellence Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Jul 02, 2024
TME Profiling Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 07, 2024
Clinical Sciences Trial Leader Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 10, 2024
Lead, RWE and Evidence Excellence Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Jul 10, 2024
Senior Statistical Programmer Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 18, 2024
Associate/Manager, MSL(Oncology) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Jul 22, 2024
Solution Design Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Sep 03, 2024
Associate/Manager, MSL (Cardiovascular) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Aug 20, 2024
Medical Field Trainer Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Aug 29, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 05, 2024
Group Manager, MSL Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Sep 05, 2024
Japan Program Clinical Head (IMM) Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Innovative Medicines Research & Development Sep 10, 2024
TA Strategy Lead - GenMed Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Okt 02, 2024
CX strategy Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Okt 04, 2024
Lead/Associate, CX Content Creation Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Okt 20, 2024
TA Strategy Lead, RLT (Prostate Cancer) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Okt 07, 2024
Lead, Integrated Insights & Planning_市場調査 Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Okt 07, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit und Finanzen Okt 06, 2024
Associate, TA Medical (General Medicines) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Okt 07, 2024
Head Regulatory Writing Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 07, 2024
Japan Program Head (Neuroscience & GTx) Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Okt 16, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.